Therapeutic targeting of CD47 using a tri-specific NK cell engager to inhibit multiple myeloma
{{output}}
Multiple myeloma (MM), a hematological malignancy, remains an incurable disease due to the development of resistance to the treatment; thus, there is an urgent need for new and effective therapeutic strategies, particularly for patients who do not respond to s... ...